ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microfluidic Technology (POCT Field) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5X17147
Home | Market Reports | Science
Global Microfluidic Technology POCT Field Market Research Report 2024
BUY CHAPTERS

Global Microfluidic Technology (POCT Field) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5X17147
Report
November 2025
Pages:209
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ThermoFisher
Parallel Fluidics
Roche
Abbott Laboratories
Danaher Life Sciences
Cepheid Inc
bioMérieux
Micronit
Bio Rad Laboratories
Zoetis Inc
Agilent Technologies
Hologic Inc
DiaSorin
Qiagen NV
Illumina Inc
Micropoint Bioscience
Singleronbio
Dichbio
Hochuen Medical Technology Co., Ltd.
Kexunanalychip
Haolitech
Honraymed
Digifluidic
Lansionbio
Each-reach
Whchip
Capitalbiotech
Bai-care
Bohui-tech
Tinkerbio
Shenzhen Xike Biomedical Technology Co., Ltd.
NewScen
Seamaty

Microfluidic Technology (POCT Field) Market

The global Microfluidic Technology (POCT Field) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Microfluidic chip, also known as Lab-on-chip, is a scientific technology whose main feature is the manipulation of fluids in micron-scale space. At present, the mainstream form of microfluidic chip refers to the integration or basic integration of basic operating units such as sample preparation, reaction, separation, detection, cell culture, sorting, lysis, etc. involved in the fields of chemistry and biology into a piece of several square centimeters or even on smaller chips, a network of microchannels is formed, with controllable fluids running through the entire system. It is a technology used to realize various functions in different laboratories such as conventional chemistry, biology, materials, and optics. The largest industrialization scenario of microfluidics lies in in vitro diagnostics.
From a downstream perspective, Medical Disease Diagnosis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Microfluidic Technology (POCT Field) leading manufacturers including Thermofisher, Parallel Fluidics, Roche, Abbott Laboratories, Danaher Life Sciences, Cepheid, BioMérieux, Micronit, Bio-Rad Laboratories, Zoetis, etc., dominate supply; the top five capture approximately % of global revenue, with Thermofisher leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Microfluidic Technology (POCT Field) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Microfluidic Technology (POCT Field) Market Report

Report Metric Details
Report Name Microfluidic Technology (POCT Field) Market
Segment by Type
  • Silicon Materials
  • Glass Quartz Material
  • Organic High Molecular Polymer Materials
  • Paper Chip Material
Segment by Application
  • Medical Disease Diagnosis
  • Pet/Animal and Plant Pathogen Detection
  • Agricultural Disease Detection
  • Food Safety Testing
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermofisher, Parallel Fluidics, Roche, Abbott Laboratories, Danaher Life Sciences, Cepheid, BioMérieux, Micronit, Bio-Rad Laboratories, Zoetis, Agilent Technologies, Hologic, Diasorin, Qiagen, Illumina, Micropoint Bioscience, Singleronbio, Dichbio, Hochuen Medical Technology Co., Ltd., Kexunanalychip, Haolitech, Honraymed, Digifluidic, Lansionbio, Each-reach, Whchip, Capitalbiotech, Bai-care, Bohui-tech, Tinkerbio, Shenzhen Xike Biomedical Technology Co., Ltd., Newscen, Seamaty
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Microfluidic Technology (POCT Field) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Microfluidic Technology (POCT Field) Market report?

Ans: The main players in the Microfluidic Technology (POCT Field) Market are Thermofisher, Parallel Fluidics, Roche, Abbott Laboratories, Danaher Life Sciences, Cepheid, BioMérieux, Micronit, Bio-Rad Laboratories, Zoetis, Agilent Technologies, Hologic, Diasorin, Qiagen, Illumina, Micropoint Bioscience, Singleronbio, Dichbio, Hochuen Medical Technology Co., Ltd., Kexunanalychip, Haolitech, Honraymed, Digifluidic, Lansionbio, Each-reach, Whchip, Capitalbiotech, Bai-care, Bohui-tech, Tinkerbio, Shenzhen Xike Biomedical Technology Co., Ltd., Newscen, Seamaty

What are the Application segmentation covered in the Microfluidic Technology (POCT Field) Market report?

Ans: The Applications covered in the Microfluidic Technology (POCT Field) Market report are Medical Disease Diagnosis, Pet/Animal and Plant Pathogen Detection, Agricultural Disease Detection, Food Safety Testing

What are the Type segmentation covered in the Microfluidic Technology (POCT Field) Market report?

Ans: The Types covered in the Microfluidic Technology (POCT Field) Market report are Silicon Materials, Glass Quartz Material, Organic High Molecular Polymer Materials, Paper Chip Material

1 Study Coverage
1.1 Introduction to Microfluidic Technology (POCT Field): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Microfluidic Technology (POCT Field) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Silicon Materials
1.2.3 Glass Quartz Material
1.2.4 Organic High Molecular Polymer Materials
1.2.5 Paper Chip Material
1.3 Market Segmentation by Application
1.3.1 Global Microfluidic Technology (POCT Field) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Disease Diagnosis
1.3.3 Pet/Animal and Plant Pathogen Detection
1.3.4 Agricultural Disease Detection
1.3.5 Food Safety Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Microfluidic Technology (POCT Field) Revenue Estimates and Forecasts 2020-2031
2.2 Global Microfluidic Technology (POCT Field) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Microfluidic Technology (POCT Field) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Microfluidic Technology (POCT Field) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Silicon Materials Market Size by Players
3.3.2 Glass Quartz Material Market Size by Players
3.3.3 Organic High Molecular Polymer Materials Market Size by Players
3.3.4 Paper Chip Material Market Size by Players
3.4 Global Microfluidic Technology (POCT Field) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Microfluidic Technology (POCT Field) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Microfluidic Technology (POCT Field) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Microfluidic Technology (POCT Field) Market Size by Type (2020-2031)
6.4 North America Microfluidic Technology (POCT Field) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Microfluidic Technology (POCT Field) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Microfluidic Technology (POCT Field) Market Size by Type (2020-2031)
7.4 Europe Microfluidic Technology (POCT Field) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Microfluidic Technology (POCT Field) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Microfluidic Technology (POCT Field) Market Size by Type (2020-2031)
8.4 Asia-Pacific Microfluidic Technology (POCT Field) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Microfluidic Technology (POCT Field) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Microfluidic Technology (POCT Field) Market Size by Type (2020-2031)
9.4 Central and South America Microfluidic Technology (POCT Field) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Microfluidic Technology (POCT Field) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Microfluidic Technology (POCT Field) Market Size by Type (2020-2031)
10.4 Middle East and Africa Microfluidic Technology (POCT Field) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Microfluidic Technology (POCT Field) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermofisher
11.1.1 Thermofisher Corporation Information
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher Microfluidic Technology (POCT Field) Product Features and Attributes
11.1.4 Thermofisher Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.1.5 Thermofisher Microfluidic Technology (POCT Field) Revenue by Product in 2024
11.1.6 Thermofisher Microfluidic Technology (POCT Field) Revenue by Application in 2024
11.1.7 Thermofisher Microfluidic Technology (POCT Field) Revenue by Geographic Area in 2024
11.1.8 Thermofisher Microfluidic Technology (POCT Field) SWOT Analysis
11.1.9 Thermofisher Recent Developments
11.2 Parallel Fluidics
11.2.1 Parallel Fluidics Corporation Information
11.2.2 Parallel Fluidics Business Overview
11.2.3 Parallel Fluidics Microfluidic Technology (POCT Field) Product Features and Attributes
11.2.4 Parallel Fluidics Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.2.5 Parallel Fluidics Microfluidic Technology (POCT Field) Revenue by Product in 2024
11.2.6 Parallel Fluidics Microfluidic Technology (POCT Field) Revenue by Application in 2024
11.2.7 Parallel Fluidics Microfluidic Technology (POCT Field) Revenue by Geographic Area in 2024
11.2.8 Parallel Fluidics Microfluidic Technology (POCT Field) SWOT Analysis
11.2.9 Parallel Fluidics Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Microfluidic Technology (POCT Field) Product Features and Attributes
11.3.4 Roche Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.3.5 Roche Microfluidic Technology (POCT Field) Revenue by Product in 2024
11.3.6 Roche Microfluidic Technology (POCT Field) Revenue by Application in 2024
11.3.7 Roche Microfluidic Technology (POCT Field) Revenue by Geographic Area in 2024
11.3.8 Roche Microfluidic Technology (POCT Field) SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Microfluidic Technology (POCT Field) Product Features and Attributes
11.4.4 Abbott Laboratories Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.4.5 Abbott Laboratories Microfluidic Technology (POCT Field) Revenue by Product in 2024
11.4.6 Abbott Laboratories Microfluidic Technology (POCT Field) Revenue by Application in 2024
11.4.7 Abbott Laboratories Microfluidic Technology (POCT Field) Revenue by Geographic Area in 2024
11.4.8 Abbott Laboratories Microfluidic Technology (POCT Field) SWOT Analysis
11.4.9 Abbott Laboratories Recent Developments
11.5 Danaher Life Sciences
11.5.1 Danaher Life Sciences Corporation Information
11.5.2 Danaher Life Sciences Business Overview
11.5.3 Danaher Life Sciences Microfluidic Technology (POCT Field) Product Features and Attributes
11.5.4 Danaher Life Sciences Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.5.5 Danaher Life Sciences Microfluidic Technology (POCT Field) Revenue by Product in 2024
11.5.6 Danaher Life Sciences Microfluidic Technology (POCT Field) Revenue by Application in 2024
11.5.7 Danaher Life Sciences Microfluidic Technology (POCT Field) Revenue by Geographic Area in 2024
11.5.8 Danaher Life Sciences Microfluidic Technology (POCT Field) SWOT Analysis
11.5.9 Danaher Life Sciences Recent Developments
11.6 Cepheid
11.6.1 Cepheid Corporation Information
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Microfluidic Technology (POCT Field) Product Features and Attributes
11.6.4 Cepheid Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.6.5 Cepheid Recent Developments
11.7 BioMérieux
11.7.1 BioMérieux Corporation Information
11.7.2 BioMérieux Business Overview
11.7.3 BioMérieux Microfluidic Technology (POCT Field) Product Features and Attributes
11.7.4 BioMérieux Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.7.5 BioMérieux Recent Developments
11.8 Micronit
11.8.1 Micronit Corporation Information
11.8.2 Micronit Business Overview
11.8.3 Micronit Microfluidic Technology (POCT Field) Product Features and Attributes
11.8.4 Micronit Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.8.5 Micronit Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Corporation Information
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Microfluidic Technology (POCT Field) Product Features and Attributes
11.9.4 Bio-Rad Laboratories Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Zoetis
11.10.1 Zoetis Corporation Information
11.10.2 Zoetis Business Overview
11.10.3 Zoetis Microfluidic Technology (POCT Field) Product Features and Attributes
11.10.4 Zoetis Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Corporation Information
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Microfluidic Technology (POCT Field) Product Features and Attributes
11.11.4 Agilent Technologies Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.11.5 Agilent Technologies Recent Developments
11.12 Hologic
11.12.1 Hologic Corporation Information
11.12.2 Hologic Business Overview
11.12.3 Hologic Microfluidic Technology (POCT Field) Product Features and Attributes
11.12.4 Hologic Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.12.5 Hologic Recent Developments
11.13 Diasorin
11.13.1 Diasorin Corporation Information
11.13.2 Diasorin Business Overview
11.13.3 Diasorin Microfluidic Technology (POCT Field) Product Features and Attributes
11.13.4 Diasorin Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.13.5 Diasorin Recent Developments
11.14 Qiagen
11.14.1 Qiagen Corporation Information
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Microfluidic Technology (POCT Field) Product Features and Attributes
11.14.4 Qiagen Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.14.5 Qiagen Recent Developments
11.15 Illumina
11.15.1 Illumina Corporation Information
11.15.2 Illumina Business Overview
11.15.3 Illumina Microfluidic Technology (POCT Field) Product Features and Attributes
11.15.4 Illumina Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.15.5 Illumina Recent Developments
11.16 Micropoint Bioscience
11.16.1 Micropoint Bioscience Corporation Information
11.16.2 Micropoint Bioscience Business Overview
11.16.3 Micropoint Bioscience Microfluidic Technology (POCT Field) Product Features and Attributes
11.16.4 Micropoint Bioscience Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.16.5 Micropoint Bioscience Recent Developments
11.17 Singleronbio
11.17.1 Singleronbio Corporation Information
11.17.2 Singleronbio Business Overview
11.17.3 Singleronbio Microfluidic Technology (POCT Field) Product Features and Attributes
11.17.4 Singleronbio Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.17.5 Singleronbio Recent Developments
11.18 Dichbio
11.18.1 Dichbio Corporation Information
11.18.2 Dichbio Business Overview
11.18.3 Dichbio Microfluidic Technology (POCT Field) Product Features and Attributes
11.18.4 Dichbio Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.18.5 Dichbio Recent Developments
11.19 Hochuen Medical Technology Co., Ltd.
11.19.1 Hochuen Medical Technology Co., Ltd. Corporation Information
11.19.2 Hochuen Medical Technology Co., Ltd. Business Overview
11.19.3 Hochuen Medical Technology Co., Ltd. Microfluidic Technology (POCT Field) Product Features and Attributes
11.19.4 Hochuen Medical Technology Co., Ltd. Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.19.5 Hochuen Medical Technology Co., Ltd. Recent Developments
11.20 Kexunanalychip
11.20.1 Kexunanalychip Corporation Information
11.20.2 Kexunanalychip Business Overview
11.20.3 Kexunanalychip Microfluidic Technology (POCT Field) Product Features and Attributes
11.20.4 Kexunanalychip Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.20.5 Kexunanalychip Recent Developments
11.21 Haolitech
11.21.1 Haolitech Corporation Information
11.21.2 Haolitech Business Overview
11.21.3 Haolitech Microfluidic Technology (POCT Field) Product Features and Attributes
11.21.4 Haolitech Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.21.5 Haolitech Recent Developments
11.22 Honraymed
11.22.1 Honraymed Corporation Information
11.22.2 Honraymed Business Overview
11.22.3 Honraymed Microfluidic Technology (POCT Field) Product Features and Attributes
11.22.4 Honraymed Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.22.5 Honraymed Recent Developments
11.23 Digifluidic
11.23.1 Digifluidic Corporation Information
11.23.2 Digifluidic Business Overview
11.23.3 Digifluidic Microfluidic Technology (POCT Field) Product Features and Attributes
11.23.4 Digifluidic Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.23.5 Digifluidic Recent Developments
11.24 Lansionbio
11.24.1 Lansionbio Corporation Information
11.24.2 Lansionbio Business Overview
11.24.3 Lansionbio Microfluidic Technology (POCT Field) Product Features and Attributes
11.24.4 Lansionbio Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.24.5 Lansionbio Recent Developments
11.25 Each-reach
11.25.1 Each-reach Corporation Information
11.25.2 Each-reach Business Overview
11.25.3 Each-reach Microfluidic Technology (POCT Field) Product Features and Attributes
11.25.4 Each-reach Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.25.5 Each-reach Recent Developments
11.26 Whchip
11.26.1 Whchip Corporation Information
11.26.2 Whchip Business Overview
11.26.3 Whchip Microfluidic Technology (POCT Field) Product Features and Attributes
11.26.4 Whchip Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.26.5 Whchip Recent Developments
11.27 Capitalbiotech
11.27.1 Capitalbiotech Corporation Information
11.27.2 Capitalbiotech Business Overview
11.27.3 Capitalbiotech Microfluidic Technology (POCT Field) Product Features and Attributes
11.27.4 Capitalbiotech Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.27.5 Capitalbiotech Recent Developments
11.28 Bai-care
11.28.1 Bai-care Corporation Information
11.28.2 Bai-care Business Overview
11.28.3 Bai-care Microfluidic Technology (POCT Field) Product Features and Attributes
11.28.4 Bai-care Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.28.5 Bai-care Recent Developments
11.29 Bohui-tech
11.29.1 Bohui-tech Corporation Information
11.29.2 Bohui-tech Business Overview
11.29.3 Bohui-tech Microfluidic Technology (POCT Field) Product Features and Attributes
11.29.4 Bohui-tech Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.29.5 Bohui-tech Recent Developments
11.30 Tinkerbio
11.30.1 Tinkerbio Corporation Information
11.30.2 Tinkerbio Business Overview
11.30.3 Tinkerbio Microfluidic Technology (POCT Field) Product Features and Attributes
11.30.4 Tinkerbio Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.30.5 Tinkerbio Recent Developments
11.31 Shenzhen Xike Biomedical Technology Co., Ltd.
11.31.1 Shenzhen Xike Biomedical Technology Co., Ltd. Corporation Information
11.31.2 Shenzhen Xike Biomedical Technology Co., Ltd. Business Overview
11.31.3 Shenzhen Xike Biomedical Technology Co., Ltd. Microfluidic Technology (POCT Field) Product Features and Attributes
11.31.4 Shenzhen Xike Biomedical Technology Co., Ltd. Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.31.5 Shenzhen Xike Biomedical Technology Co., Ltd. Recent Developments
11.32 Newscen
11.32.1 Newscen Corporation Information
11.32.2 Newscen Business Overview
11.32.3 Newscen Microfluidic Technology (POCT Field) Product Features and Attributes
11.32.4 Newscen Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.32.5 Newscen Recent Developments
11.33 Seamaty
11.33.1 Seamaty Corporation Information
11.33.2 Seamaty Business Overview
11.33.3 Seamaty Microfluidic Technology (POCT Field) Product Features and Attributes
11.33.4 Seamaty Microfluidic Technology (POCT Field) Revenue and Gross Margin (2020-2025)
11.33.5 Seamaty Recent Developments
12 Microfluidic Technology (POCT Field)Industry Chain Analysis
12.1 Microfluidic Technology (POCT Field) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Microfluidic Technology (POCT Field) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Microfluidic Technology (POCT Field) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
ThermoFisher
Parallel Fluidics
Roche
Abbott Laboratories
Danaher Life Sciences
Cepheid Inc
bioMérieux
Micronit
Bio Rad Laboratories
Zoetis Inc
Agilent Technologies
Hologic Inc
DiaSorin
Qiagen NV
Illumina Inc
Micropoint Bioscience
Singleronbio
Dichbio
Hochuen Medical Technology Co., Ltd.
Kexunanalychip
Haolitech
Honraymed
Digifluidic
Lansionbio
Each-reach
Whchip
Capitalbiotech
Bai-care
Bohui-tech
Tinkerbio
Shenzhen Xike Biomedical Technology Co., Ltd.
NewScen
Seamaty
List of Tables
 Table 1. Global Microfluidic Technology (POCT Field) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Microfluidic Technology (POCT Field) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Microfluidic Technology (POCT Field) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Microfluidic Technology (POCT Field) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Microfluidic Technology (POCT Field) Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Microfluidic Technology (POCT Field) Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Microfluidic Technology (POCT Field) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microfluidic Technology (POCT Field) as of 2024)
 Table 11. Global Microfluidic Technology (POCT Field) Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Microfluidic Technology (POCT Field) Companies Headquarters
 Table 13. Global Microfluidic Technology (POCT Field) Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Microfluidic Technology (POCT Field) Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Microfluidic Technology (POCT Field) Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Microfluidic Technology (POCT Field) Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Microfluidic Technology (POCT Field) Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Microfluidic Technology (POCT Field) High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Microfluidic Technology (POCT Field) Growth Accelerators and Market Barriers
 Table 25. North America Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Microfluidic Technology (POCT Field) Growth Accelerators and Market Barriers
 Table 27. Europe Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Microfluidic Technology (POCT Field) Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Microfluidic Technology (POCT Field) Investment Opportunities and Key Challenges
 Table 31. Central and South America Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Microfluidic Technology (POCT Field) Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Microfluidic Technology (POCT Field) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Thermofisher Corporation Information
 Table 35. Thermofisher Description and Major Businesses
 Table 36. Thermofisher Product Features and Attributes
 Table 37. Thermofisher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Thermofisher Revenue Proportion by Product in 2024
 Table 39. Thermofisher Revenue Proportion by Application in 2024
 Table 40. Thermofisher Revenue Proportion by Geographic Area in 2024
 Table 41. Thermofisher Microfluidic Technology (POCT Field) SWOT Analysis
 Table 42. Thermofisher Recent Developments
 Table 43. Parallel Fluidics Corporation Information
 Table 44. Parallel Fluidics Description and Major Businesses
 Table 45. Parallel Fluidics Product Features and Attributes
 Table 46. Parallel Fluidics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Parallel Fluidics Revenue Proportion by Product in 2024
 Table 48. Parallel Fluidics Revenue Proportion by Application in 2024
 Table 49. Parallel Fluidics Revenue Proportion by Geographic Area in 2024
 Table 50. Parallel Fluidics Microfluidic Technology (POCT Field) SWOT Analysis
 Table 51. Parallel Fluidics Recent Developments
 Table 52. Roche Corporation Information
 Table 53. Roche Description and Major Businesses
 Table 54. Roche Product Features and Attributes
 Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Roche Revenue Proportion by Product in 2024
 Table 57. Roche Revenue Proportion by Application in 2024
 Table 58. Roche Revenue Proportion by Geographic Area in 2024
 Table 59. Roche Microfluidic Technology (POCT Field) SWOT Analysis
 Table 60. Roche Recent Developments
 Table 61. Abbott Laboratories Corporation Information
 Table 62. Abbott Laboratories Description and Major Businesses
 Table 63. Abbott Laboratories Product Features and Attributes
 Table 64. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Abbott Laboratories Revenue Proportion by Product in 2024
 Table 66. Abbott Laboratories Revenue Proportion by Application in 2024
 Table 67. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
 Table 68. Abbott Laboratories Microfluidic Technology (POCT Field) SWOT Analysis
 Table 69. Abbott Laboratories Recent Developments
 Table 70. Danaher Life Sciences Corporation Information
 Table 71. Danaher Life Sciences Description and Major Businesses
 Table 72. Danaher Life Sciences Product Features and Attributes
 Table 73. Danaher Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Danaher Life Sciences Revenue Proportion by Product in 2024
 Table 75. Danaher Life Sciences Revenue Proportion by Application in 2024
 Table 76. Danaher Life Sciences Revenue Proportion by Geographic Area in 2024
 Table 77. Danaher Life Sciences Microfluidic Technology (POCT Field) SWOT Analysis
 Table 78. Danaher Life Sciences Recent Developments
 Table 79. Cepheid Corporation Information
 Table 80. Cepheid Description and Major Businesses
 Table 81. Cepheid Product Features and Attributes
 Table 82. Cepheid Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Cepheid Recent Developments
 Table 84. BioMérieux Corporation Information
 Table 85. BioMérieux Description and Major Businesses
 Table 86. BioMérieux Product Features and Attributes
 Table 87. BioMérieux Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. BioMérieux Recent Developments
 Table 89. Micronit Corporation Information
 Table 90. Micronit Description and Major Businesses
 Table 91. Micronit Product Features and Attributes
 Table 92. Micronit Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Micronit Recent Developments
 Table 94. Bio-Rad Laboratories Corporation Information
 Table 95. Bio-Rad Laboratories Description and Major Businesses
 Table 96. Bio-Rad Laboratories Product Features and Attributes
 Table 97. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Bio-Rad Laboratories Recent Developments
 Table 99. Zoetis Corporation Information
 Table 100. Zoetis Description and Major Businesses
 Table 101. Zoetis Product Features and Attributes
 Table 102. Zoetis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Zoetis Recent Developments
 Table 104. Agilent Technologies Corporation Information
 Table 105. Agilent Technologies Description and Major Businesses
 Table 106. Agilent Technologies Product Features and Attributes
 Table 107. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Agilent Technologies Recent Developments
 Table 109. Hologic Corporation Information
 Table 110. Hologic Description and Major Businesses
 Table 111. Hologic Product Features and Attributes
 Table 112. Hologic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Hologic Recent Developments
 Table 114. Diasorin Corporation Information
 Table 115. Diasorin Description and Major Businesses
 Table 116. Diasorin Product Features and Attributes
 Table 117. Diasorin Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Diasorin Recent Developments
 Table 119. Qiagen Corporation Information
 Table 120. Qiagen Description and Major Businesses
 Table 121. Qiagen Product Features and Attributes
 Table 122. Qiagen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Qiagen Recent Developments
 Table 124. Illumina Corporation Information
 Table 125. Illumina Description and Major Businesses
 Table 126. Illumina Product Features and Attributes
 Table 127. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Illumina Recent Developments
 Table 129. Micropoint Bioscience Corporation Information
 Table 130. Micropoint Bioscience Description and Major Businesses
 Table 131. Micropoint Bioscience Product Features and Attributes
 Table 132. Micropoint Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Micropoint Bioscience Recent Developments
 Table 134. Singleronbio Corporation Information
 Table 135. Singleronbio Description and Major Businesses
 Table 136. Singleronbio Product Features and Attributes
 Table 137. Singleronbio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Singleronbio Recent Developments
 Table 139. Dichbio Corporation Information
 Table 140. Dichbio Description and Major Businesses
 Table 141. Dichbio Product Features and Attributes
 Table 142. Dichbio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Dichbio Recent Developments
 Table 144. Hochuen Medical Technology Co., Ltd. Corporation Information
 Table 145. Hochuen Medical Technology Co., Ltd. Description and Major Businesses
 Table 146. Hochuen Medical Technology Co., Ltd. Product Features and Attributes
 Table 147. Hochuen Medical Technology Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Hochuen Medical Technology Co., Ltd. Recent Developments
 Table 149. Kexunanalychip Corporation Information
 Table 150. Kexunanalychip Description and Major Businesses
 Table 151. Kexunanalychip Product Features and Attributes
 Table 152. Kexunanalychip Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Kexunanalychip Recent Developments
 Table 154. Haolitech Corporation Information
 Table 155. Haolitech Description and Major Businesses
 Table 156. Haolitech Product Features and Attributes
 Table 157. Haolitech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Haolitech Recent Developments
 Table 159. Honraymed Corporation Information
 Table 160. Honraymed Description and Major Businesses
 Table 161. Honraymed Product Features and Attributes
 Table 162. Honraymed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Honraymed Recent Developments
 Table 164. Digifluidic Corporation Information
 Table 165. Digifluidic Description and Major Businesses
 Table 166. Digifluidic Product Features and Attributes
 Table 167. Digifluidic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Digifluidic Recent Developments
 Table 169. Lansionbio Corporation Information
 Table 170. Lansionbio Description and Major Businesses
 Table 171. Lansionbio Product Features and Attributes
 Table 172. Lansionbio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 173. Lansionbio Recent Developments
 Table 174. Each-reach Corporation Information
 Table 175. Each-reach Description and Major Businesses
 Table 176. Each-reach Product Features and Attributes
 Table 177. Each-reach Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 178. Each-reach Recent Developments
 Table 179. Whchip Corporation Information
 Table 180. Whchip Description and Major Businesses
 Table 181. Whchip Product Features and Attributes
 Table 182. Whchip Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 183. Whchip Recent Developments
 Table 184. Capitalbiotech Corporation Information
 Table 185. Capitalbiotech Description and Major Businesses
 Table 186. Capitalbiotech Product Features and Attributes
 Table 187. Capitalbiotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 188. Capitalbiotech Recent Developments
 Table 189. Bai-care Corporation Information
 Table 190. Bai-care Description and Major Businesses
 Table 191. Bai-care Product Features and Attributes
 Table 192. Bai-care Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 193. Bai-care Recent Developments
 Table 194. Bohui-tech Corporation Information
 Table 195. Bohui-tech Description and Major Businesses
 Table 196. Bohui-tech Product Features and Attributes
 Table 197. Bohui-tech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 198. Bohui-tech Recent Developments
 Table 199. Tinkerbio Corporation Information
 Table 200. Tinkerbio Description and Major Businesses
 Table 201. Tinkerbio Product Features and Attributes
 Table 202. Tinkerbio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 203. Tinkerbio Recent Developments
 Table 204. Shenzhen Xike Biomedical Technology Co., Ltd. Corporation Information
 Table 205. Shenzhen Xike Biomedical Technology Co., Ltd. Description and Major Businesses
 Table 206. Shenzhen Xike Biomedical Technology Co., Ltd. Product Features and Attributes
 Table 207. Shenzhen Xike Biomedical Technology Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 208. Shenzhen Xike Biomedical Technology Co., Ltd. Recent Developments
 Table 209. Newscen Corporation Information
 Table 210. Newscen Description and Major Businesses
 Table 211. Newscen Product Features and Attributes
 Table 212. Newscen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 213. Newscen Recent Developments
 Table 214. Seamaty Corporation Information
 Table 215. Seamaty Description and Major Businesses
 Table 216. Seamaty Product Features and Attributes
 Table 217. Seamaty Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 218. Seamaty Recent Developments
 Table 219. Raw Materials Key Suppliers
 Table 220. Distributors List
 Table 221. Market Trends and Market Evolution
 Table 222. Market Drivers and Opportunities
 Table 223. Market Challenges, Risks, and Restraints
 Table 224. Research Programs/Design for This Report
 Table 225. Key Data Information from Secondary Sources
 Table 226. Key Data Information from Primary Sources


List of Figures
 Figure 1. Microfluidic Technology (POCT Field) Product Picture
 Figure 2. Global Microfluidic Technology (POCT Field) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Silicon Materials Product Picture
 Figure 4. Glass Quartz Material Product Picture
 Figure 5. Organic High Molecular Polymer Materials Product Picture
 Figure 6. Paper Chip Material Product Picture
 Figure 7. Global Microfluidic Technology (POCT Field) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Medical Disease Diagnosis
 Figure 9. Pet/Animal and Plant Pathogen Detection
 Figure 10. Agricultural Disease Detection
 Figure 11. Food Safety Testing
 Figure 12. Microfluidic Technology (POCT Field) Report Years Considered
 Figure 13. Global Microfluidic Technology (POCT Field) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Microfluidic Technology (POCT Field) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Microfluidic Technology (POCT Field) Revenue Market Share by Region (2020-2031)
 Figure 17. Global Microfluidic Technology (POCT Field) Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Silicon Materials Revenue Market Share by Player in 2024
 Figure 20. Glass Quartz Material Revenue Market Share by Player in 2024
 Figure 21. Organic High Molecular Polymer Materials Revenue Market Share by Player in 2024
 Figure 22. Paper Chip Material Revenue Market Share by Player in 2024
 Figure 23. Global Microfluidic Technology (POCT Field) Revenue Market Share by Type (2020-2031)
 Figure 24. Global Microfluidic Technology (POCT Field) Revenue Market Share by Application (2020-2031)
 Figure 25. North America Microfluidic Technology (POCT Field) Revenue YoY (2020-2031) & (US$ Million)
 Figure 26. North America Top 5 Players Microfluidic Technology (POCT Field) Revenue (US$ Million) in 2024
 Figure 27. North America Microfluidic Technology (POCT Field) Revenue (US$ Million) by Type (2020 - 2031)
 Figure 28. North America Microfluidic Technology (POCT Field) Revenue (US$ Million) by Application (2020-2031)
 Figure 29. US Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 30. Canada Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 31. Mexico Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 32. Europe Microfluidic Technology (POCT Field) Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. Europe Top 5 Players Microfluidic Technology (POCT Field) Revenue (US$ Million) in 2024
 Figure 34. Europe Microfluidic Technology (POCT Field) Revenue (US$ Million) by Type (2020-2031)
 Figure 35. Europe Microfluidic Technology (POCT Field) Revenue (US$ Million) by Application (2020-2031)
 Figure 36. Germany Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 37. France Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 38. U.K. Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 39. Italy Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 40. Russia Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Microfluidic Technology (POCT Field) Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Top 8 Players Microfluidic Technology (POCT Field) Revenue (US$ Million) in 2024
 Figure 43. Asia-Pacific Microfluidic Technology (POCT Field) Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Asia-Pacific Microfluidic Technology (POCT Field) Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Indonesia Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 46. Japan Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 47. South Korea Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 48. Australia Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 49. India Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 50. Indonesia Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 51. Vietnam Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 52. Malaysia Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 53. Philippines Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 54. Singapore Microfluidic Technology (POCT Field) Revenue (2020-2031) & (US$ Million)
 Figure 55. Central and South America Microfluidic Technology (POCT Field) Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Central and South America Top 5 Players Microfluidic Technology (POCT Field) Revenue (US$ Million) in 2024
 Figure 57. Central and South America Microfluidic Technology (POCT Field) Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Central and South America Microfluidic Technology (POCT Field) Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Brazil Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 60. Argentina Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 61. Middle East and Africa Microfluidic Technology (POCT Field) Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Middle East and Africa Top 5 Players Microfluidic Technology (POCT Field) Revenue (US$ Million) in 2024
 Figure 63. South America Microfluidic Technology (POCT Field) Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Middle East and Africa Microfluidic Technology (POCT Field) Revenue (US$ Million) by Application (2020-2031)
 Figure 65. GCC Countries Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 66. Israel Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 67. Egypt Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 68. South Africa Microfluidic Technology (POCT Field) Revenue (2020-2025) & (US$ Million)
 Figure 69. Microfluidic Technology (POCT Field) Industry Chain Mapping
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global POCT Microfluidic Chip Market Research Report 2024
Global Microfluidics IVD Field Market Research Report 2024
Global Microfluidic Chip Solution Market Research Report 2024
Microfluidics Market
Global Microfluidic Chip in Biomedical Field Market Research Report 2024
Microfluidic Chips Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microfluidics Components Market Insights Forecast to 2030
Global Lab on Chips Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Microfluidic Devices Market Research Report 2024
Global Medical Microfluidic Devices Market Insights Forecast to 2030
Global Microfluidic Control Solutions Market Research Report 2024
Global Microfluidic Element Market Insights Forecast to 2030
Global Microfluidic Chip Testing Equipment Market Research Report 2024
Global Microfluidic Control Device Market Research Report 2024
Global Glass Microfluidic Chip Market Research Report 2025
Global Microfluidic Droplet Chip Market Research Report 2025
Global Polymer based Microfluidic Chips Market Research Report 2025
Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Research Report 2024
Global Lab on a chip LOC Market Research Report 2025
Global Microfluidic Chip Customization Service Market Research Report 2024

RELATED REPORTS

Global Sensors for Humanoid Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34E19768
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Magnetic Electrode Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2C20273
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Geiger Radiation Detector Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35E19945
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Laboratory Refrigerated Centrifuge Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21O7910
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions